Trexquant Investment LP Sells 410,550 Shares of LifeStance Health Group, Inc. $LFST

Key Points

• Trexquant Investment LP reduced its holdings in LifeStance Health Group by 59.3%, now owning approximately 281,487 shares worth $1.87 million.
• Multiple hedge funds purchased new stakes in LifeStance Health Group, with institutional investors collectively owning 85.50% of the company's stock.
• LifeStance Health Group reported a 10.6% year-over-year increase in revenue for the most recent quarter and adjusted its EPS guidance for FY 2025 to -0.18.

Trexquant Investment LP trimmed its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 59.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 281,487 shares of the company's stock after selling 410,550 shares during the period. Trexquant Investment LP owned approximately 0.07% of LifeStance Health Group worth $1,875,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Landscape Capital Management L.L.C. purchased a new position in shares of LifeStance Health Group during the first quarter valued at approximately $5,135,000. Virtus Advisers LLC purchased a new position in shares of LifeStance Health Group during the first quarter valued at approximately $132,000. AlphaQuest LLC lifted its holdings in shares of LifeStance Health Group by 144.2% during the first quarter. AlphaQuest LLC now owns 112,814 shares of the company's stock valued at $751,000 after purchasing an additional 66,621 shares during the last quarter. EntryPoint Capital LLC raised its holdings in LifeStance Health Group by 171.9% in the 1st quarter. EntryPoint Capital LLC now owns 87,591 shares of the company's stock worth $583,000 after acquiring an additional 55,382 shares during the last quarter. Finally, Hsbc Holdings PLC raised its holdings in LifeStance Health Group by 5.8% in the 1st quarter. Hsbc Holdings PLC now owns 112,189 shares of the company's stock worth $743,000 after acquiring an additional 6,182 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other LifeStance Health Group news, Director Darren M. Black sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the completion of the sale, the director owned 33,524,715 shares of the company's stock, valued at approximately $169,970,305.05. The trade was a 20.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the sale, the insider directly owned 33,524,715 shares of the company's stock, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,407,643 shares of company stock valued at $103,466,750. Company insiders own 3.20% of the company's stock.

LifeStance Health Group Stock Performance

NASDAQ:LFST traded down $0.32 during trading hours on Wednesday, reaching $5.17. The company had a trading volume of 2,102,995 shares, compared to its average volume of 2,556,785. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 52 week low of $3.74 and a 52 week high of $8.61. The firm has a market cap of $2.01 billion, a price-to-earnings ratio of -103.40 and a beta of 1.17. The firm's 50 day moving average price is $4.79 and its 200-day moving average price is $5.78.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. During the same quarter in the previous year, the firm posted ($0.06) EPS. The firm's revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Analysts Set New Price Targets

LFST has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. BTIG Research initiated coverage on shares of LifeStance Health Group in a report on Friday, July 25th. They issued a "buy" rating and a $8.00 price objective for the company. Finally, UBS Group boosted their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of "Moderate Buy" and a consensus target price of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.